These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S. Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675 [Abstract] [Full Text] [Related]
6. Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate-transfused patients. Jain N, Sarkar S, Philip J. Immunohematology; 2014 Feb; 30(3):123-5. PubMed ID: 25695438 [Abstract] [Full Text] [Related]
9. Platelet transfusion refractoriness and anti-HLA immunization. Blandin L, Dougé A, Fayard A, Bay JO, Berlie G, Pereira B, Lemal R, Rouzaire P. Transfusion; 2021 Jun; 61(6):1700-1704. PubMed ID: 33709433 [Abstract] [Full Text] [Related]
10. Determination in vivo viability of a transfused platelet product by corrected count increment and percentage platelet response. Thuku NW, Shikuku K, Mbugua A. Pan Afr Med J; 2017 Jun; 27():226. PubMed ID: 28979628 [Abstract] [Full Text] [Related]
11. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management. Panch SR, Guo L, Vassallo R. Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287 [Abstract] [Full Text] [Related]
12. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Novotny VM, van Doorn R, Witvliet MD, Claas FH, Brand A. Blood; 1995 Apr 01; 85(7):1736-41. PubMed ID: 7703481 [Abstract] [Full Text] [Related]
13. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Brouk H, Bertrand G, Zitouni S, Djenouni A, Martageix C, Griffi F, Kaplan C, Ouelaa H. Transfus Apher Sci; 2015 Jun 01; 52(3):295-9. PubMed ID: 25620758 [Abstract] [Full Text] [Related]
18. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med; 1997 Dec 25; 337(26):1861-9. PubMed ID: 9417523 [Abstract] [Full Text] [Related]
19. Use of HLA- and HPA--matched platelets in alloimmunized patients. Kekomäki R. Vox Sang; 1998 Dec 25; 74 Suppl 2():359-63. PubMed ID: 9704468 [Abstract] [Full Text] [Related]
20. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients. Jia Y, Li W, Liu N, Zhang K, Gong Z, Li D, Wang L, Wang D, Jing Y, Wang J, Shan X. Transfus Med; 2014 Dec 25; 24(6):406-10. PubMed ID: 25327352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]